Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John L Lamattina Insider Profile
4 Followers
John L Lamattina, Director at PureTech Health, holds 1.51M shares in PureTech Health (Ticker: GB:PRTC). Most recently, John L Lamattina Bought 6,700p shares of PureTech Health on May 21, 2020 for an estimated value of 16.75K.
Profitable Transactions
9 out of 9 Profitable Transactions
Average Return
+11.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John L Lamattina's holdings
Insider Roles
Director
Roles that John L Lamattina holds in companies
Most Profitable Insider Trade
The most profitable trade made by John L Lamattina
John L Lamattina's Trading History
List of latest transactions for each holding click on a transaction to see John L Lamattina's performance on stock
You May Also Like
John L Lamattina insider profile FAQ
What is the percentage of profitable transactions made by John L Lamattina?
The percentage of profitable transactions made by John L Lamattina is 100%.
What is the average return per transaction made by John L Lamattina?
The average return per transaction made by John L Lamattina is 11.50%.
What stocks does John L Lamattina hold?
John L Lamattina holds: GB:PRTC stocks.
What was John L Lamattina’s latest transaction?
John L Lamattina latest transaction was an Informative Buy of 16.75K.
What was John L Lamattina's most profitable transaction?
John L Lamattina’s most profitable transaction was an Informative Buy of GB:PRTC stock on May 20, 2020. The return on the trade was 24.00%.
What is John L Lamattina's role in PureTech Health?
John L Lamattina's role in PureTech Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.